RespireRx Pharmaceuticals Statistics
Total Valuation
RSPI has a market cap or net worth of $328,877. The enterprise value is $2.54 million.
| Market Cap | 328,877 |
| Enterprise Value | 2.54M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
RSPI has 365.42 million shares outstanding. The number of shares has increased by 124.49% in one year.
| Shares Outstanding | 365.42M |
| Shares Change (YoY) | +124.49% |
| Shares Change (QoQ) | +59.16% |
| Owned by Insiders (%) | 6.63% |
| Owned by Institutions (%) | n/a |
| Float | 353.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,354,715.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,789.35% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$972,191 |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RSPI has paid $358,678 in taxes.
| Income Tax | 358,678 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.33% in the last 52 weeks. The beta is 0.53, so RSPI's price volatility has been lower than the market average.
| Beta (1Y) | 0.53 |
| 52-Week Price Change | -73.33% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 46.74 |
| Average Volume (30 Days) | 11,580,592 |
Short Selling Information
The latest short interest is 126, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 126 |
| Short Previous Month | 245 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | 1.47 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.41M |
| Pretax Income | -1.81M |
| Net Income | -1.94M |
| EBITDA | -1.48M |
| EBIT | -390.91B |
| Earnings Per Share (EPS) | -$0.01 |
Balance Sheet
The company has $6,362 in cash and $2.21 million in debt, giving a net cash position of -$2.21 million or -$0.01 per share.
| Cash & Cash Equivalents | 6,362 |
| Total Debt | 2.21M |
| Net Cash | -2.21M |
| Net Cash Per Share | -$0.01 |
| Equity / Book Value | -12.30M |
| Book Value Per Share | -0.03 |
| Working Capital | -11.95M |
Cash Flow
| Operating Cash Flow | -247,570 |
| Capital Expenditures | n/a |
| Free Cash Flow | -247,570 |
| FCF Per Share | -$0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RSPI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -124.49% |
| Shareholder Yield | -124.49% |
| Earnings Yield | -591.22% |
| FCF Yield | -75.28% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 6, 2021. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 6, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |